MKK6 deficiency promotes cardiac dysfunction through MKK3-p38γ/δ-mTOR hyperactivation
Rafael Romero-Becerra, Alfonso Mora, Elisa Manieri, Ivana Nikolić, Ayelén Melina Santamans, Valle Montalvo-Romeral, Francisco Miguel Cruz, Elena Rodríguez, Marta León, Luis Leiva‐Vega, Laura Sanz, Víctor Bondía, David Filgueiras Rama, Luis Jesús Jiménez‐Borreguero, José Jalife, , Guadalupe Sabio
This paper shows that MKK6 deficiency leads to cardiac dysfunction through hyperactivation of the MKK3-p38γ/δ-mTOR pathway, causing hypertrophy and fibrosis, and highlights potential cardiotoxicity of p38 inhibitors.
eLife · Jul 11, 2022Peer-reviewedMolecular Biology